Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
PDGFB
REST API REST API
Homo sapiens
PDGFB is differentially expressed in 259 experiments: 127 organism parts: thymus, kidney, ... (125 more);, 226 disease states: normal, lung adenocarcinoma, ... (224 more);, 69 cell types 366 cell lines 37 compound treatments and 67 other conditions.
Synonyms SSV, SIS
Orthologs PDGFB (1 of 3) (Danio rerio)   PDGFB (2 of 3) (Danio rerio)   Pdgfb (Mus musculus)   pdgfb (Danio rerio)   F1NE37_CHICK (Gallus gallus)   Q58D48_BOVIN (Bos taurus)   Pdgfb (Rattus norvegicus)   pdgfb (Xenopus laevis)   PDGFB_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term positive regulation of cell division, negative regulation of transcription, DNA-dependent, protein binding, response to wounding, cytoplasm, regulation of cell proliferation, peptidyl-serine phosphorylation, wound healing, positive regulation of cell proliferation, membrane, Golgi membrane, eukaryotic cell surface binding, peptidyl-tyrosine phosphorylation, growth factor activity, protein tyrosine kinase activity, transforming growth factor beta receptor signaling pathway, extracellular region, positive regulation of MAP kinase activity, blood coagulation, response to hypoxia, cell growth, basolateral plasma membrane, hemopoiesis, actin cytoskeleton organization, cell projection assembly, heart development, negative regulation of cell migration, protein heterodimerization activity, positive regulation of DNA replication, response to drug, protein homodimerization activity, activation of protein kinase activity, cell surface, cell surface binding, endoplasmic reticulum lumen, positive regulation of transcription, DNA-dependent, DNA replication, activation of protein kinase B activity, cellular response to mycophenolic acid, cell chemotaxis, superoxide-generating NADPH oxidase activator activity, platelet degranulation, positive regulation of smooth muscle cell migration, regulation of peptidyl-tyrosine phosphorylation, positive regulation of peptidyl-tyrosine phosphorylation, positive regulation of ERK1 and ERK2 cascade, negative regulation of phosphatidylinositol biosynthetic process, branching involved in salivary gland morphogenesis, platelet-derived growth factor receptor signaling pathway, positive regulation of cell migration, response to estrogen stimulus, positive regulation of chemotaxis, blood vessel development, response to insulin stimulus, positive regulation of fibroblast proliferation, response to estradiol stimulus, epithelial cell proliferation involved in salivary gland morphogenesis, positive regulation of cyclin-dependent protein kinase activity, platelet-derived growth factor binding, monocyte chemotaxis, collagen binding, response to organic substance, positive regulation of endothelial cell proliferation, positive regulation of smooth muscle cell proliferation, negative regulation of platelet activation, positive regulation of blood vessel endothelial cell migration, positive regulation of MAPKKK cascade, positive regulation of fibroblast growth factor receptor signaling pathway, positive regulation of protein tyrosine kinase activity, platelet-derived growth factor receptor binding, positive regulation of mitosis, embryonic placenta development, platelet activation, protein phosphorylation, positive regulation of protein autophosphorylation, platelet alpha granule lumen, paracrine signaling, positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway, metanephric glomerular mesangial cell proliferation involved in metanephros development, positive regulation of metanephric mesenchymal cell migration, positive regulation of glomerular filtration, metanephric glomerular endothelium development, response to organic cyclic compound, substrate-dependent cell migration, positive regulation of reactive oxygen species metabolic process, positive regulation of phosphatidylinositol 3-kinase activity, positive regulation of calcium ion import, reactive oxygen species metabolic process, positive regulation of phosphatidylinositol 3-kinase cascade, positive regulation of glomerular mesangial cell proliferation, metanephric glomerular mesangial cell development, positive regulation of DNA biosynthetic process
InterPro Term PD_growth_factor, PDGF_N
UniProt Accession Q15354, A9UJP0, A9UJN9, Q9UE56, Q9UE57, P01127, P78450
Gene-Disease Assocation DERMATOFIBROSARCOMA PROTUBERANS; DFSP
Search EB-eye ENSG00000100311
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-GEOD-803, E-GEOD-6573, E-GEOD-3526, E-MTAB-62, ... (25 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-MEXP-1006, E-GEOD-19639, E-GEOD-18005, ... (35 experiments)

Factor Value U/D Experiments
SW480
4
E-GEOD-18005, E-MEXP-1014, E-GEOD-2509, E-MTAB-37
MCF-7
3
E-GEOD-20081, E-GEOD-5823, E-GEOD-19639
PC3
3
E-GEOD-5258, E-MEXP-2034, E-GEOD-14464
CCRFCEM
2
E-GEOD-24147, E-MTAB-37
HCC1143
2
E-MTAB-37, E-MTAB-62
NCIH1092
1
E-MTAB-37
360 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-3920, E-MEXP-66, E-GEOD-20677, E-GEOD-13987, ... (42 experiments)

Factor Value U/D Experiments
endothelial cell
1
3
E-GEOD-3920, E-GEOD-3998, E-GEOD-96, E-GEOD-19240
CD4+ T cell
1
2
E-GEOD-16190, E-MTAB-24, E-MTAB-25
CD34+ hematopoietic progenitor cell
1
E-GEOD-19240
basophil
1
E-GEOD-3982
centroblast
1
E-TABM-702
Leukocytes
1
E-GEOD-21909
63 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-TABM-15, E-MTAB-62, E-GEOD-5418, ... (52 experiments)

Factor Value U/D Experiments
lung adenocarcinoma
4
E-MTAB-37, E-GEOD-2514, E-MEXP-231, E-MTAB-62
AIDS-KS, HIV+, nodular (late) stage
2
2
E-MTAB-62, E-MEXP-66
acute lymphoblastic leukemia
2
E-MTAB-62, E-MTAB-37
colon carcinoma
2
E-MTAB-37, E-MTAB-62
control
2
E-GEOD-21912, E-GEOD-20295
gastric carcinoma
2
E-GEOD-15460, E-GEOD-2685
220 more value(s).


Compound treatment

studied in E-GEOD-15205, E-TABM-782, E-GEOD-5824, E-GEOD-5099, E-GEOD-6462, ... (18 experiments)

Factor Value U/D Experiments
glucose
1
E-MEXP-941
non-targeting
1
E-MEXP-2218
interleukin-4 (Homo sapiens) + anti-CD40
1
E-GEOD-7307
TTA
1
E-MEXP-2590
anti-CD3 + anti-CD28
1
E-GEOD-7307
unknown
1
E-GEOD-7307
31 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
tunicamycin
1
1
E-GEOD-19519


Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-MEXP-1251, E-GEOD-21589, E-GEOD-16363, ... (8 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-2171, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-5999, E-GEOD-4667, E-MEXP-2283, E-MTAB-62 ... (5 experiments)

Dfs follow up
studied in E-GEOD-22541

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-89, E-GEOD-19743, E-MTAB-69, E-GEOD-2509, E-TABM-147, ... (6 experiments)

Environmental stress
studied in E-GEOD-1518

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-6431

Genotype
studied in E-GEOD-17476, E-TABM-321, E-GEOD-18736, E-TABM-868, E-TABM-601, ... (6 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-GEOD-20504, E-GEOD-3003, E-GEOD-837, ... (6 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-GEOD-21653

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-2069, E-MEXP-1648, E-GEOD-16363, ... (28 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-12254, E-MEXP-561, E-GEOD-17400, E-GEOD-6802 ... (5 experiments)

Injury
studied in E-GEOD-19743

Localisation of metastases
studied in E-GEOD-22541

Material type
studied in E-MEXP-455, E-MEXP-958, E-MEXP-1082, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Performer
studied in E-GEOD-2004

Phenotype
studied in E-GEOD-26495, E-GEOD-1309, E-GEOD-21750, E-GEOD-1657, E-GEOD-17636 ... (5 experiments)

Population
studied in E-MTAB-197, E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, ... (6 experiments)

Replicate
studied in E-GEOD-10797, E-GEOD-10896

RNAi
studied in E-GEOD-12438, E-MEXP-1509, E-MEXP-101, E-MEXP-548, E-GEOD-3697, ... (6 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

Stimulation
studied in E-GEOD-20114

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-13818, E-GEOD-12198

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4271, E-GEOD-4922, E-TABM-147

Tumor size
studied in E-GEOD-8167

Vehicle
studied in E-GEOD-5258

weight of protein recovered
studied in E-GEOD-21918

Processing time: 0.356 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM